Skip to main content

Table 6 Frequency of HER-2 expression for lymph-node status by joint ER/PR expression

From: Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma

 

No

N+

 

HER-2

HER-2

 

Negative

Positive

Total

Negative

Positive

Total

ER- PR-

27(90%)

3 (10%)

30

7 (35%)

13 (65%)

20

ER- PR+

7 (100%)

0 (0%)

7

1 (16.7%)

5 (83.3%)

6

ER+ PR-

14 (100%)

0(0%)

14

7 (77.8%)

2 (22.2%)

9

ER+ PR+

38 (97,4%)

1(2.6%)

39

25 (86,2%)

4 (13,8%)

29

Total

86 (95.55)

4(3.45)

90

40 (62.5)

24 (37.5)

64

  1. N0: without lymph node involvement; N+: with lymph node involvement; HER-2: Human epidermal growth factor receptor 2; ER: Estrogen receptor; PR: Progesterone receptor.